Publication | Closed Access
Poly(Acrylic Acid) Modification of Nd<sup>3+</sup>‐Sensitized Upconversion Nanophosphors for Highly Efficient UCL Imaging and pH‐Responsive Drug Delivery
259
Citations
44
References
2015
Year
NanoparticlesNanotherapeuticsEngineeringSmart PolymerResponsive PolymersBiomedical EngineeringProtein NanoparticlesNanomedicineUpconversion NanophosphorsAcrylic AcidTherapeutic NanomaterialsBioimagingChemodynamic TherapyDrug Delivery SystemHybrid MaterialsMolecular ImagingPolymer ChemistryBiological NanomaterialsUpconversion LuminescenceExcited UcnpsUpconversion Luminescence IntensityBiomolecular EngineeringNanomaterialsPolymer-drug ConjugatePharmaceutical NanotechnologyDrug Delivery SystemsNano-drug DeliveryMedicinePh‐responsive Drug Delivery
In this work, a simple method is demonstrated for the synthesis of multifunctional core–shell nanoparticles NaYF 4 :Yb,Er@NaYF 4 :Yb@NaNdF 4 :Yb@NaYF 4 :Yb@PAA (labeled as Er@Y@Nd@Y@PAA or UCNP@PAA), which contain a highly effective 808‐nm‐to‐visible UCNP core and a thin shell of poly(acrylic acid) (PAA) to achieve upconversion bioimaging and pH‐sensitive anticancer chemotherapy simultaneously. The core–shell Nd 3+ ‐sensitized UCNPs are optimized by varying the shell number, core size, and host lattices. The final optimized Er@Y@Nd@Y nanoparticle composition shows a significantly improved upconversion luminescence intensity, that is, 12.8 times higher than Er@Y@Nd nanoparticles. After coating the nanocomposites with a thin layer of PAA, the resulting UCNP@PAA nanocomposite perform well as a pH‐responsive nanocarrier and show clear advantages over UCNP@mSiO 2 , which are evidenced by in vitro/in vivo experiments. Histological analysis also reveals that no pathological changes or inflammatory responses occur in the heart, lungs, kidneys, liver, and spleen. In summary, this study presents a major step forward towards a new therapeutic and diagnostic treatment of tumors by using 808‐nm excited UCNPs to replace the traditional 980‐nm excitation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1